Moreover, an antibody blocking the interaction of FGF19 to FGFR4 limited the formation of colon tumor xenografts in vivo, preventing hepatocellular carcinomas in FGF19 transgenic mice [165]. This evidence concerns the gene FGF19 and hepatocellular carcinoma.